Reference
NICE. NICE recommends edoxaban (Lixiana) for preventing potentially fatal blood clots in people with atrial fibrillation. Media Release : 23 Sep 2015. Available from: URL: http://www.nice.org.uk
Rights and permissions
About this article
Cite this article
NICE: final guidance recommends edoxaban. PharmacoEcon Outcomes News 738, 34 (2015). https://doi.org/10.1007/s40274-015-2516-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2516-9